Dorros G, Cohn J M
St. Luke's Medical Center, Milwaukee, Wisconsin, USA.
J Endovasc Surg. 1996 Aug;3(3):270-2. doi: 10.1583/1074-6218(1996)003<0270:AITCAE>2.0.CO;2.
To present a cardiac asystole technique that assists in the accurate deployment of stent-grafts during endovascular repair of thoracic or abdominal aortic aneurysms.
In the anesthetized patient, trial doses of intravenous adenosine are delivered until a > or = 20-second period of asystole is recorded. The endograft procedure then proceeds until the device is ready for deployment. The predetermined dose of adenosine is administered, and the device is deployed during asystole. Adenosine-induced transient asystole has been utilized in 16 patients undergoing balloon-expandable endograft exclusion of 6 thoracic aortic and 10 abdominal aortic aneurysms. Asystole lasted for 20 to 30 seconds, during which time the devices were accurately deployed without interference from the aortic flow. There were no clinical sequelae of this technique in any patient.
Pharmacologically induced transient asystole appears to be a safe maneuver to preclude endograft movement by systolic blood flow. The technique permits precise placement of balloon-expandable stent-grafts and is applicable to self-expanding devices as well. Interventionists may wish to incorporate adenosine-induced asystole into their aortic aneurysm exclusion procedures.
介绍一种心脏停搏技术,该技术有助于在胸主动脉或腹主动脉瘤的血管内修复过程中准确地植入覆膜支架。
在麻醉状态下的患者中,静脉注射腺苷试验剂量,直至记录到心脏停搏持续≥20秒。然后进行腔内修复手术,直至装置准备好植入。给予预定剂量的腺苷,并在心脏停搏期间植入装置。腺苷诱导的短暂心脏停搏已应用于16例接受球囊扩张型腔内修复术治疗6例胸主动脉瘤和10例腹主动脉瘤的患者。心脏停搏持续20至30秒,在此期间,装置被准确植入,不受主动脉血流干扰。该技术在任何患者中均未产生临床后遗症。
药物诱导的短暂心脏停搏似乎是一种安全的操作,可防止覆膜支架因收缩期血流而移动。该技术允许精确放置球囊扩张型覆膜支架,也适用于自膨式装置。介入医生可能希望将腺苷诱导的心脏停搏纳入其主动脉瘤修复手术中。